Brand new report "Neurodegenerative Diseases: World Drug Market 2011-2026" published by Visiongain

All sectors of the market have been expanding, but which will fare best from 2010 onwards? How will those submarkets, and the overall market sector, cope with patent expiries this decade? How will leading national markets perform from 2010 to 2026?
By: Visiongain Ltd.
 
Nov. 4, 2010 - PRLog -- Report Details
- how you can find demand and revenue trends there

Would you like to know how the industry and market for neurodegenerative drug treatments will develop? There will be trends to watch from 2010 onwards, especially areas of revenue growth. You can have our new report now, staying ahead, saving time and aiding your decisions.

The number of patients may quadruple worldwide by 2050. Yet, there remain significant unmet needs in all sectors of the neurodegenerative treatments market.

You can assess those commercial opportunities now, with us providing forecasts for the following drug markets from 2010 to 2026:
• Multiple sclerosis
• Alzheimer's disease
• Parkinson's disease
• Neuropathies
• Huntington's disease
• Amyotrophic lateral sclerosis.

Our new report analyses and discusses strengths, weaknesses and revenue trends of the sector from 2009 to 2026.

All sectors of the market have been expanding, but which will fare best from 2010 onwards? How will those submarkets, and the overall market sector, cope with patent expiries this decade? How will leading national markets perform from 2010 to 2026? What opportunities are there for resolving unmet therapeutic needs?

We show you where the neurodegenerative drug treatment sector is heading. Our report shows you its technological and commercial potential, revealing opportunities, challenges and requirements for success there.

New drugs with improved safety and efficacy can gain significant market shares from 2010 onwards. There remain high revenues to be made in this sector from 2010 to 2026, as we show and explain.

New treatment types - such as oral agents for MS - could re-shape the market from this decade onwards. There will be commercial growth, with important trends to watch.

We show how you could make gains there. Our report makes it quick and practical for you to assess the potential of the industry and market now.

Analysis and expert views to aid your work - so you won't be left behind

Our new report provides you with revenue forecasts, market share analyses, R&D pipeline developments and expert opinion. That way, you can assess prospects, opportunities and threats in the sector. It is that combination of data that sets us apart.

We include 98 tables and figures and two expert interviews (shown in the accompanying lists). You can stay ahead by ordering our report today, benefiting your analyses and commercial ideas.

World Neurodegenerative Diseases: World Drug Market 2011-2026 shows you revenue trends, opportunities and challenges

Our report gives you the following advantages:
• You will receive hard data for the neurodegenerative diseases sector - especially our revenue forecasts - helping you to stay ahead
• You will discover revenue trends for the overall market and its main components from 2009 to 2026 - showing you where commercial potential will lie
• You will find revenue predictions for leading national markets from 2009 to 2026 (US, Japan, UK, Germany, France, Spain, Italy, China and India)
• You will learn how the sector can change and adapt from 2010 to 2026
• You will assess leading organisations in neurodegenerative disease treatment, discovering their activities and prospects
• You will discover the drivers, restraints, competition and opportunities influencing this sector, including oral agents for MS, outcomes of research and drug targets
• You will investigate unmet and under-met needs in that sector, with therapeutic requirements and commercial opportunities discussed
• You will review R&D pipelines, assessing the potential of developments
• You will view expert opinion from our survey, including interview transcripts
• You will find out where the sector is heading - technology, competition, revenues and other aspects of the industry and market.

You can have our report today

Our new study can benefit everybody interested in the neurodegenerative disease treatment market. You can see where the industry and market are heading, assessing the opportunities, requirements and challenges there.

You can find answers and trends - we aim to save you time and aid your decisions. Order our report now, making sure you don't miss out. Please let us help today.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Contact Person:

Bijal Patel
bijal.patel@visiongainglobal.com
0044(0)20 7549 9946

# # #

Visiongain is an independent business information provider for the Telecoms, Pharmaceutical and Defence industries. We organise conferences, publish reports and newsletters, and provide consultancy services.
End
Source:Visiongain Ltd.
Email:***@visiongainglobal.com Email Verified
Zip:EC1V 2QY
Tags:Neurodegenerative Diseases, Neurodegenerative Drug, Neuropathies, Multiple Sclerosis, Alzheimer S Disease
Industry:Media, Science, Research
Location:England
Account Email Address Verified     Disclaimer     Report Abuse
Visiongain reports PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share